Navigation Links
ViroPharma To Release 2013 Second Quarter Financial Results On August 1, 2013

EXTON, Pa., July 25, 2013 /PRNewswire/ -- ViroPharma Incorporated's (Nasdaq: VPHM) second quarter financial results for 2013 are expected to be released on Thursday, August 1, 2013 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day.  During the conference call, ViroPharma management will discuss the 2013 second quarter financial results along with other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at  An audio archive will be available at the same address until August 15, 2013.  To participate in the conference call, please dial (800) 874-4559 (domestic) and (302) 607-2019 (international).  After placing the call, please tell the operator you wish to join the ViroPharma investor conference call. 

About ViroPharma Incorporated
ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options. ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, cytomegalovirus (CMV), Friedreich's Ataxia, eosinophilic esophagitis (EoE) and adrenal insufficiency. Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve. ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures in children and adolescents, adrenal insufficiency and C. difficile-associated diarrhea (CDAD). For full U.S. prescribing information on our products, please download the package inserts at; the prescribing information for other countries can be found at

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, The company encourages investors to consult these sections for more information on ViroPharma and our business.

SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. ViroPharma To Participate In Two May Healthcare Investor Conferences
2. ViroPharma Announces First Quarter 2013 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
4. ViroPharma to Participate in Two December Healthcare Investor Conferences
5. New Vacuum Catalog, UHV Compatible Motorized Positioners, Linear Stages, Rotary Stages, Beamline Instrumentation Released by PI miCos
6. NSG Precision Cells Announces the Release of High Quality Calibration Standards for UV-VIS Spectrophotometers
7. NEBA Health Releases Key Study Results for the first FDA approved brain wave test to help clinicians assess ADHD in children and adolescents
8. NSG Has Just Released Its NIST 930e Photometric Accuracy Standard Kit for Spectrometer Calibration and It's Changing the Spectroscopy World
9. Bend Research Presents Drug Delivery Advancements at Controlled Release Society Annual Meeting
10. Chemical Publishing Company to Release New Title Boiler Water Treatment Principles and Practice: Charts and Notes for Field Use
11. Patheon to Showcase Controlled Release Capabilities at CRS 2013
Post Your Comments:
(Date:10/13/2015)... , October 13, 2015 the United ... Europe .  PRCC represents about 14% of all new cases ... , Canada and Europe ... kidney cancer.   --> Hutchison China MediTech Limited ("Chi-Med") ... R&D subsidiary, and AstraZeneca AB (publ) ("AstraZeneca") have completed enrolment in ...
(Date:10/12/2015)... , Oct. 12, 2015  Rebiotix Inc. ... (FDA) has designated its lead Microbiota Restoration Therapy ... treatment of recurrent Clostridium difficile (C ... infection that causes 29,000 deaths in the U.S. ... biotechnology company that was founded to revolutionize the ...
(Date:10/12/2015)... , October 12, 2015 ... Dario™ Diabetes Management Solution, today announced its Medical Director, ... case study at MobiHealth,s 5th EAI International Conference ... "Transforming healthcare through innovations in mobile and wireless technologies," ... England from October 14 - 16, 2015. ...
(Date:10/12/2015)... CA (PRWEB) , ... October 12, 2015 , ... ... announced the launch of LifeTrak Zoom, the world’s first amphibious fitness tracker that seeks ... that offers flexwear technology and accurate heart rate monitoring both in water ...
Breaking Biology Technology:
(Date:9/30/2015)... -- The global glucose monitoring device and diabetes management market is ... report on the industry from Kalorama Information. Sales in the traditional ... by continuous glucose monitoring and sensor segment, according to the ... products in its latest report, The Global Glucose Monitoring ... , ...
(Date:9/28/2015)... -- The global image sensors market ... by 2020, growing at a CAGR of 4.6% from ... (BSI) technique to improve picture quality are expected to ...      (Logo: , The light falls ... and, thus, reduce the noise interference and increase picture ...
(Date:9/24/2015)... LONDON , September 24, 2015 /PRNewswire/ ... 00.01 25 september 2015 Kerv ... inom digitala finanstjänster, lanserar idag världens första ... att samla in 77 000 GBP för ... ) , ...
Breaking Biology News(10 mins):